Please login to the form below

Not currently logged in

off label

This page shows the latest off label news and features for those working in and with pharma, biotech and healthcare.

Reviews start for Pfizer’s wildcard lung cancer drug dacomitinib

Reviews start for Pfizer’s wildcard lung cancer drug dacomitinib

There have also been reports that some oncologists are already using the drug off-label in treatment-naïve patients.

Latest news

More from news
Approximately 4 fully matching, plus 177 partially matching documents found.

Latest Intelligence

  • Significant figures Significant figures

    Fast forward to last September and the company’s decision to put ALIS through phase III trials paid off, when it released late-stage results showing 29% of patients with NTM ... or less off-label as it’s not specifically indicated to treat the

  • Healthcare systems

    Healthcare terms - Healthcare systems.

  • The gold standard of scientific evidence The gold standard of scientific evidence

    More than one in five prescriptions in the United States are for an off-label use; providing additional evidence to better understand treatment efficacy and safety is crucial.

  • Creative marketing and compliance Creative marketing and compliance

    Sales people can be using marketing content in good faith, without realising that it is 'off label' and unapproved. ... Get it wrong and not only is there the risk of being 'off brand' (it could even be a matter of life or death), but local regulations

  • Does safety sell medicines? Does safety sell medicines?

    New legislation in Europe introduced in 2012 has also led companies to expand what they collect from just side effects to reports of occupational exposure, off-label use and medication errors. ... Through the collection and review of adverse event

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Established in 2002, Star is a full service outsourcing and resourcing company that works with the best people and opportunities...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...